Navigation Links
Shire Announces Publication of Open-Label Study on Coadministration of INTUNIV(TM) (guanfacine) Extended-Release Tablets with Stimulants
Date:11/16/2009

oses them to syncope; are treated concomitantly with antihypertensives or other drugs that can reduce blood pressure or heart rate or increase the risk of syncope. Heart rate and blood pressure should be measured prior to initiation of therapy, following dose increases, and periodically while on therapy. Patients should be advised to avoid becoming dehydrated or overheated.

Sedation and somnolence were commonly observed in clinical trials. The potential for additive sedative effects with CNS depressant drugs should be considered. Patients should be cautioned against operating heavy equipment or driving until they know how they respond to INTUNIV. Avoid use with alcohol.

Common adverse reactions in patients taking INTUNIV that may be dose related over the range of 1 to 4 mg/day include somnolence, sedation, abdominal pain, dizziness, hypotension/decreased blood pressure, dry mouth, and constipation.

About ADHD

ADHD is one of the most common psychiatric disorders in children and adolescents. Worldwide prevalence of ADHD is estimated at 5.3 percent (with large variability), according to a comprehensive systematic review of this topic published in 2007 in the American Journal of Psychiatry. In the United States, approximately 7.8 percent of all school-aged children, or about 4.4 million children aged 4 to 17 years, have been diagnosed with ADHD at some point in their lives, according to the Centers for Disease Control and Prevention (CDC).

ADHD is a psychiatric behavioral disorder that manifests as a persistent pattern of inattention and/or hyperactivity-impulsivity that is more frequent and severe than is typically observed in individuals at a comparable level of development. The specific etiology of ADHD is unknown and there is no single diagnostic test for this disorder. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources, utilizing
'/>"/>

SOURCE Shire plc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
(Date:5/22/2015)... China , May 22, 2015  China Nepstar ... "Company"), a leading retail drugstore chain in ... operated stores, today announced the resignation of Mr. ... for personal reasons, effective immediately. Ms. Rebecca Yingnan ... by the Company,s board of directors, effective immediately. Meanwhile, ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... and size the world market for Arthroscopy ... identifies trends impacting the market for these ...
Breaking Medicine Technology:2015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3
... , , SANTA CLARA, Calif., Dec. ... diagnostic and services company, today announced that Dr. Ihor Gussak, ... join a distinguished roster of speakers, moderators and panelists at ... Assessment Summit. The Conference is scheduled for January 12 and ...
... YORK, Dec. 22 Delcath Systems, Inc. (Nasdaq: DCTH ... for primary and metastatic cancers to the liver, announced today ... Board, effective immediately. , "We formed our Scientific Advisory ... PHP System(TM) with insight from the leading experts in regional ...
Cached Medicine Technology:NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 2NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 4Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board 2Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board 3
(Date:5/22/2015)... Raton, FL (PRWEB) May 22, 2015 ... which provides vascular, electrocardiogram (EKG), echocardiogram and NCV ... David Sempier, a highly respected All American National athlete, ... multi-sport athlete, I find the high level of testing ... both the athlete and their athletic trainers, this way ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President and ... by Consulting-Specifying Engineer (CSE) magazine as a young leader ... the May/June issue of the publication. , This award ... and younger who have, and continue to make significant ... other areas of their professional and personal endeavors. Candidates ...
(Date:5/22/2015)... Bryce Henson, local fitness icon and owner ... recently accepted his program’s 100th client. Henson says that ... his location evidences the powerful impact his boot camp ... Boot Camp is the nation’s most popular and fastest ... locations across North America, Europe and Australia. Anaheim Fit ...
(Date:5/22/2015)... 2015 Javon Bea Mercy Health ... for providing the highest quality emergency care services, especially ... decision-making,” said Javon R. Bea, President and CEO of ... our employee/partners to care for and respond to what ... not apply for this award, but are selected if ...
(Date:5/21/2015)... 21, 2015 Her popular Love Seminar will ... Hotel in San Gabriel on Saturday, May 23rd. , ... from men and women who are unhappy in their relationships ... , "Many singles think that their biggest problem is not ... go from one relationship to another trying to find the ...
Breaking Medicine News(10 mins):Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2
... plain flacon from among the possessions of Pharaoh Hatshepsut, who ... permanent collection of the Egyptian Museum of the University of ... have held a deadly secret. This is what the Head ... the university,s Pharmacology Institute just discovered. After two years of ...
... , THURSDAY, Aug. 18 (HealthDay News) -- A ... seems to provide insight into the likelihood that certain patients ... attack or stroke, researchers say. The test to ... should take cholesterol-lowering drugs to reduce their cardiovascular risks, the ...
... Antibiotics can help ward off serious bacterial infections in kidney ... treatments. But if antibiotics are used too often, "super bugs" ... A new randomized controlled clinical trial has shown that using ... serious infections may be a safe way to prevent bacterial ...
... (August 18, 2011) AMRI (NASDAQ: AMRI) today ... the National Institutes of Health (NIH)/National Institute of ... and other drug discovery technologies in support of ... of the NIH Blueprint Neurotherapeutics Network. AMRI ...
... News) -- Cases of Legionnaire,s disease in the United States ... report shows. And while Legionnaires, disease is serious and ... for concern, most people recover with antibiotic treatment, officials said. ... Centers for Disease Control and Prevention rose from 1,110 in ...
... By Denise Mann HealthDay Reporter , THURSDAY, Aug. ... seasonal flu and H1N1, just like last year,s, but that ... researchers from the U.S. Centers for Disease Control and Prevention ... should be vaccinated," said Dr. Carolyn Bridges, an associate director ...
Cached Medicine News:Health News:Deadly medication? 2Health News:Deadly medication? 3Health News:Test for Calcium Buildup May Spot Heart Attack, Stroke Risk 2Health News:Acne-treating antibiotic cuts catheter infections in dialysis patients 2Health News:AMRI receives NIH contract award for development of pre-clinical drug candidates 2Health News:Cases of Legionnaire's Disease Tripled in 10 Years 2Health News:Don't Skip This Year's Flu Shot: CDC 2
... Albumin Cobalt Binding (ACB®) Test is a ... Albumin (IMA®) by measuring the cobalt binding ... sample. First identified in the early 1990s, ... in contact with ischemic tissue in the ...
... ELISA products for autoimmune testing feature single-well ... well as specific reflex tests including dsDNA, ... SS-A (Ro), SS-B (La), Scl-70 and Jo-1. ... a full line of products for Cardiolipins ...
... Diagnostics is a leading provider of immunofluorescence ... test menu that includes kits for autoimmune ... as miscellaneous conjugates and components. Our Impact ... assortment of substrates and kit sizes to ...
... Our ELISA products for autoimmune testing ... ELISAs, as well as specific reflex tests ... Sm, Sm/RNP, SS-A (Ro), SS-B (La), Scl-70 ... family includes a full line of products ...
Medicine Products: